Searched for
PHARMACEUTICAL ENFORCEMENT ACTIONS
Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers are also facing intensive audits amid quality concernsThe government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...- 'You are using sword to kill mosquito': Bombay HC tells Tukaram Mundhe-led FDA to use power judiciouslyThe Bombay High Court has told the Tukaram Mundhe-led Maharashtra FDA to use its powers judiciously after Cadila Pharmaceuticals challenged...
- FSSAI suspends Kolkata bakery major Switz Foods' licence over unhygienic manufacturing, pest infestationIndia's food regulator has suspended Switz Foods' manufacturing licence. Serious non-compliances were found during a recent unit inspection...
- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plantThe FSSAI has suspended Dior Pharmaceuticals' license due to serious violations. The nutraceutical factory operated with severely deficient...
- India to host two-day BRICS anti-drug agencies meet in Guwahati from July 6Guwahati will host a crucial two-day BRICS meeting from July 6, bringing together anti-drug agency heads to bolster intelligence sharing an...
- Guwahati hosts BRICS meet amid rising synthetic drug threatIndia is set to host the BRICS Anti-Drug Agencies Meeting in Guwahati from July 6-7. This crucial gathering aims to bolster intelligence sh...
- Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...
- India Inc wary of fresh trade headwinds as US weighs additional 12.5% tariffIndia faces a potential 12.5% US tariff on imports following a Section 301 investigation into forced labor import prohibitions. Industry le...
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- India attracted $843 billion in FDI between 2014-15 and 2025-26: OfficialIndia has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...
- NCLAT quashes Ligare Aviation's insolvency; loan from Religare Enterprises round-tripping of moneyThe National Company Law Appellate Tribunal has cancelled insolvency proceedings against Ligare Aviation. The tribunal found the National C...
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
- US plans additional 12.5% tariff; India says talks on Section 301 probes ongoingThe US Trade Representative has proposed an additional 12.5% duty on 54 countries, including India, over alleged failure to restrict import...
- Trump administration proposes 25% tariff to punish Brazil over trade practicesThe United States is proposing a 25% tariff on many imports from Brazil. This action follows an investigation into unfair trade practices. ...
- US FDA stepping up enforcement of pharma ad rules, sends letters to companiesThe Trump administration is intensifying its scrutiny of pharmaceutical advertising, with the FDA set to issue cease-and-desist notices and...
- Government forms committee to regulate marketing practices of pharma companiesThe panel includes secretary of the department of pharmaceuticals S Aparna, Union health secretary Rajesh Bhushan, and Central Board of Dir...
- USTR puts India on ‘priority watch list’ on 'Intellectual Property' concernsThe US said that these countries will be the subject of increased bilateral engagement with the USTR to address IP concerns
- Pharmaceutical industry agrees to enforcement of marketing code: Indian Pharmaceutical AlliancePharma industry has agreed in principle to enforce a code that will restrict them from offering gifts or other sops to doctors in order to ...
Load More
